| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2006.08.3063 |
| P698 | PubMed publication ID | 17159190 |
| P50 | author | Jennifer L Griggs | Q80975418 |
| P2093 | author name string | Gary H Lyman | |
| Jeffrey Crawford | |||
| Michelle van Ryn | |||
| David C Dale | |||
| Eva Culakova | |||
| Melony E S Sorbero | |||
| Marek S Poniewierski | |||
| Debra A Wolff | |||
| P2860 | cites work | The effect of patient race and socio-economic status on physicians' perceptions of patients | Q56688987 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| patient | Q181600 | ||
| chemotherapy | Q974135 | ||
| socioeconomics | Q1643441 | ||
| P304 | page(s) | 277-84 | |
| P577 | publication date | 2007-01-20 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy | |
| P478 | volume | 25 |
| Q37187652 | A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer. |
| Q43492558 | Absence of cancer diagnosis and treatment in elderly Medicaid-insured nursing home residents |
| Q35492458 | Adjuvant chemotherapy dosing in low-income women: the impact of Hispanic ethnicity and patient self-efficacy |
| Q37919151 | Anticoagulating obese patients in the modern era. |
| Q33637040 | Availability and utility of body mass index for population-based cancer surveillance |
| Q36514371 | Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment |
| Q36569214 | Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population |
| Q33709643 | Bone marrow transplantation in AML, and socioeconomic class: a UK population-based cohort study |
| Q34659874 | Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice |
| Q47733110 | Can complementary medicine increase adherence to chemotherapy dosing protocol? A controlled study in an integrative oncology setting |
| Q37272646 | Cancer and disparities in health: perspectives on health statistics and research questions |
| Q38121735 | Chemotherapy dosing in overweight and obese patients with cancer |
| Q37477083 | Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey |
| Q36240745 | Chemotherapy was not associated with cognitive decline in older adults with breast and colorectal cancer: findings from a prospective cohort study. |
| Q36438347 | Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality |
| Q34459673 | Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelines |
| Q38833853 | Do race/ethnicity or socioeconomic status affect why we place ear tubes in children? |
| Q80809590 | Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy |
| Q38978525 | Education Level is a Strong Prognosticator in the Subgroup Aged More Than 50 Years Regardless of the Molecular Subtype of Breast Cancer: Study Based on the Nationwide Korean Breast Cancer Registry Database. |
| Q34565516 | Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study |
| Q37459580 | Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study |
| Q37065947 | Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample |
| Q40915725 | Financial Quality of Life for Patients With Cancer: An Exploratory Study. |
| Q36053032 | Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index |
| Q53618240 | Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials. |
| Q37180380 | Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity |
| Q39568666 | Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426). |
| Q40092913 | Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012. |
| Q38772800 | Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis. |
| Q37361918 | Life-Threatening Disparities: The Treatment of Black and White Cancer Patients |
| Q43245975 | Obesity and angiolymphatic invasion in primary breast cancer. |
| Q48241850 | Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study |
| Q35684496 | Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support |
| Q37161492 | Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. |
| Q42766829 | Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy |
| Q57108049 | Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis |
| Q46092963 | Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study |
| Q45982211 | Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival. |
| Q53805731 | Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system. |
| Q35095664 | Reducing Racial Health Care Disparities: A Social Psychological Analysis |
| Q36075221 | Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the Netherlands |
| Q36567692 | Socio-economic status and survival from breast cancer for young, Australian, urban women |
| Q47405559 | Socioeconomic differences in survival among breast cancer patients in the Netherlands not explained by tumor size |
| Q37337695 | Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer |
| Q64111092 | The Impact of Obesity on Breast Cancer Diagnosis and Treatment |
| Q34407878 | The combined effect of individual and neighborhood socioeconomic status on cancer survival rates |
| Q43902443 | The early discontinuation of palliative chemotherapy in older patients with cancer |
| Q36152955 | The role of obesity in cancer survival and recurrence |
| Q38130610 | Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis |
| Q38180008 | Treatment and outcomes in diabetic breast cancer patients |
| Q42017011 | Undertreatment of Cancer Patients With Chemotherapy Is a Global Concern |
| Q46053394 | Uptake and patterns of use of gemcitabine for metastatic pancreatic cancer: a population-based study |
| Q36495460 | Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer |
| Q36724704 | Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis |
| Q35984047 | Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia |
Search more.